Man­u­fac­tur­ing roundup: Finnish phar­ma Ori­on in­vest­ing $30M+ to boost pro­duc­tion; Biosyn­gen opens new Sin­ga­pore fa­cil­i­ty

The Finnish phar­ma­ceu­ti­cal com­pa­ny Ori­on is plan­ning to in­vest around €30 mil­lion ($32.7 mil­lion) to boost its pro­duc­tion ca­pac­i­ty.

Ac­cord­ing to a re­lease, this in­vest­ment …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER